Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis

被引：0

作者：

Emery, Paul ^{[2
]}

van Vollenhoven, Ronald F. ^{[1
]}

Binghamlll, Clifton O. ^{[3
]}

Keystone, Edward C. ^{[4
]}

Greenwald, Maria ^{[5
]}

Moreland, Larry W. ^{[6
]}

Sweetser, Marianne ^{[7
]}

Rowe, Karen ^{[8
]}

Wagner, Bridget ^{[9
]}

Magrini, Fabio ^{[8
]}

机构：

[1] Karolinska Univ Hosp, Dept Rheumatol, Stockholm, Sweden

[2] Leeds Gen Infirm, Dept Rheumatol, Leeds, W Yorkshire, England

[3] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[4] Univ Toronto, Dept Med, Toronto, ON, Canada

[5] Desert Med Adv, Palm Desert, CA USA

[6] Univ Alabama, Sch Med, Dept Med, Birmingham, AL USA

[7] Biogen Idec, Drug Safety & Risk Management, Cambridge, MA USA

[8] Roche Prod Ltd, Med Sci, Welwyn Garden City AL7 3AY, Herts, England

[9] Drug Safety Genentech Inc, San Francisco, CA USA

来源：

RHEUMATOLOGY | 2008年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：II16 / II16

页数：1

共 50 条

[1] Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis
van Vollenhoven, Ronald
Haraoui, Boulos
Emery, Paul
Bingham, Clifton
Keystone, Edward
Greenwald, Maria
Moreland, Larry
Sweetser, Marianne
Rowe, Karen
Wagner, Bridget
Magrini, Fabio
[J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1187 - 1188
[2] Long-term safety data from extended follow-up and repeat use of rituximab in rheumatoid arthritis
van Vollenhoven, R.
Emery, R.
Bingham, C.
Keystone, E.
Greenwald, M.
Moreland, L. W.
Sweetser, M.
Rowe, K.
Wagner, B.
Magrini, F.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 89
[3] LONG-TERM SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: LONG-TERM FOLLOW-UP OF CLINICAL TRIALS AND RETREATMENT POPULATION
van Vollenhoven, Ronald F.
Emery, Paul
Bingham, Clifton O.
Keystone, Edward C.
Fleischmann, Roy M.
Furst, Daniel E.
Macey, Katherine
Sweetster, Marianne T.
Lehane, Patricia B.
Farmer, Pamela
Long, Simon G.
[J]. RHEUMATOLOGY, 2010, 49 : I104 - I104
[4] LONG-TERM SAFETY OF RITUXIMAB: FOLLOW-UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS AND RETREATMENT POPULATION
Van Vollenhoven, R.
Littlejohn, G.
Emery, P.
Bingham, C.
Keystone, E.
Fleischmann, R.
Furst, D.
Jones, G.
Tyson, N.
Collinson, N.
Lehane, P.
[J]. INTERNAL MEDICINE JOURNAL, 2011, 41 : 18 - 18
[5] LONG-TERM SAFETY OF RITUXIMAB: FOLLOW UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS
van Vollenhoven, Ronald
Emery, Paul
Bingham, Clifton, III
Keystone, Edward
Fleischmann, Roy M.
Furst, Daniel E.
Macey, Katherine M.
Sweetser, Marianne T.
Lehane, Patricia
Farmer, Pamela
Long, Simon G.
[J]. RHEUMATOLOGY, 2011, 50 : 127 - 128
[6] LONG-TERM USE OF RITUXIMAB IN RHEUMATOID ARTHRITIS: 17 YEARS FOLLOW-UP
Ismajli, Mediola
Ionescu, Raluca
Moore, Samantha
Leandro, Maria
[J]. RHEUMATOLOGY, 2017, 56 : 142 - 142
[7] Long-term safety data from extended follow-up and repeat use of Rituximab (RTX) in patients with active rheumatoid arthritis (RA)
Ronald, Van Vollenhoven
Tore, Kvien
Jean, Sibilia
Paul, Emery
Clifton, Bingham
Edward, Keystone
Maria, Greenwald
Larry, Moreland
Marrianne, Sweetser
Karen, Rowe
Bridget, Wagner
Fabio, Magrini
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 51 - 51
[8] JUVENILE RHEUMATOID ARTHRITIS - A LONG-TERM FOLLOW-UP
BARKIN, RE
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1952, 11 (04) : 316 - 317
[9] LONG-TERM SAFETY OF RITUXIMAB: 10-YEAR FOLLOW-UP IN THE RHEUMATOID ARTHRITIS GLOBAL CLINICAL TRIAL PROGRAMME
van Vollenhoven, R. F.
Emery, P.
Bingham, C. O.
Keystone, E.
Fleischmann, R.
Furst, D. E.
Tyson, N.
Mehbob, A.
Lehane, P. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 195 - 195
[10] Long-Term Safety of Rituximab: 10-Year Follow-up in the Rheumatoid Arthritis Global Clinical Trial Program.
van Vollenhoven, Ronald F.
Emery, Paul
Bingham, Clifton O., III
Keystone, Edward
Fleischmann, Roy M.
Furst, Daniel E.
Tyson, Nicola
Mehbob, Abdul
Lehane, Patrica B.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S199 - S199

← 1 2 3 4 5 →